{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:11:53Z","timestamp":1761430313855,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1080\/146532401317070880","type":"journal-article","created":{"date-parts":[[2002,10,29]],"date-time":"2002-10-29T15:58:43Z","timestamp":1035907123000},"page":"253-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies"],"prefix":"10.1016","volume":"3","author":[{"given":"G.","family":"G\u00fcrman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Arat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Konuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Beksa\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"\u00c7elebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6.","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Akan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/146532401317070880_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","article-title":"Bone marrow transplantation for chronic myelogenous leukemia in chronic phase Increased risk of relapse associated with Tcell depletion","volume":"108","author":"Goldman","year":"1988","journal-title":"Ann Int Med"},{"key":"10.1080\/146532401317070880_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1080\/146532401317070880_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1080\/146532401317070880_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1080\/146532401317070880_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.1998.01057.x","article-title":"Evidence of cytogenetic and molecular remission by allogeneic cells after imunosuppressive therapy alone","volume":"103","author":"Carella","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1080\/146532401317070880_bib6","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: induction of graft-versus-malignancy using fludarabine based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1080\/146532401317070880_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.1999.01706.x","article-title":"Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect","volume":"107","author":"Childs","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1080\/146532401317070880_bib8","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versushost disease in H-2-incompatible transplanted SCID mice","volume":"83","author":"Xun","year":"1994","journal-title":"Blood"},{"key":"10.1080\/146532401317070880_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1701540","article-title":"Fludarabine-based nonmyeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukemia and lymphoma","volume":"23","author":"Grigg","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1080\/146532401317070880_bib10","first-page":"519a","article-title":"Outpatient PBSC allografts using immunosuppression with low dose TBI before, and cyclosporine (CSP) and mycophenolate mofetil (MMF) after transplant","volume":"92","author":"McSweeney","year":"1998","journal-title":"Blood"},{"key":"10.1080\/146532401317070880_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701628","article-title":"Epstein\u2013Barr virus associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation","volume":"23","author":"Milpied","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1080\/146532401317070880_bib12","first-page":"S129","article-title":"Invasive fungal infections following reduced conditioning for matched allogeneic stem cell transplantation (alloSCT)","volume":"25","author":"Nagler","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1080\/146532401317070880_bib13","first-page":"S133","article-title":"Non-myeloablative conditioning regimen in allogeneic peripheral blood stem cell transplantation (alloPBSCT) for high risk hematologic malignancies \u2014 preliminary results","volume":"25","author":"Vaz","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/146532401317070880_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2141.2000.01809.x","article-title":"The combined effect of total body irradiation (TBI) and cyclosporine A (CsA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation","volume":"108","author":"Bacigalupo","year":"2000","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1080\/146532401317070880_bib15","first-page":"S26","article-title":"A nonmyeloablative regimen for allogeneic stem cell transplantation with a low incidence of GvHD","volume":"25","author":"Kottaridis","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/146532401317070880_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1701167","article-title":"Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukaemia undergoing BMT preconditioned with a new, non-myeloablative drug combination","volume":"21","author":"Kelemen","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/146532401317070880_bib17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohaematopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation","volume":"353","author":"Sykes","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1080\/146532401317070880_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bmt.1702100","article-title":"Hematopoietic stem cell allografts using a nonmyeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases","volume":"25","author":"Gomez-Almaguer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/146532401317070880_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood.V95.1.67","article-title":"Comparison of single dose and escalating dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukaemia","volume":"95","author":"Dazzi","year":"2000","journal-title":"Blood"},{"key":"10.1080\/146532401317070880_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1701323","article-title":"Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions","volume":"22","author":"Fuchs","year":"1998","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324901709887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324901709887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:07:30Z","timestamp":1761430050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324901709887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S1465324901709887"],"URL":"https:\/\/doi.org\/10.1080\/146532401317070880","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/146532401317070880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}